CISION PRNewswire

61512 posts

Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business

Acquisition supports Servier’s strategic ambition in rare neurology with sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies.   The acquired asset and expert team strengthen Servier’s commitment to innovate for…
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.77 Million Tokens, and Total Crypto and Total Cash Holdings of .3 Billion

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.77 Million Tokens, and Total Crypto and Total Cash Holdings of $11.3 Billion

Bitmine owns 4.8% of the total ETH coin supply of 120.7 million…
Tomocube Launches HT-T1 Desktop for 3D Glass Substrate Defect Analysis in Advanced Packaging

Tomocube Launches HT-T1 Desktop for 3D Glass Substrate Defect Analysis in Advanced Packaging

Provides non-destructive 3D analysis of the location, morphology, and depth profile of…

LEIFRAS Co., Ltd. Forms Strategic Alliance with HR Produce, Leveraging Its Network of Over 10,000 Preschools to Accelerate Expansion into Japan's Preschool Market

Partnership Provides Access to an Extensive Childcare Facility Network to Scale Leifras’…
BUSINESSES CONTINUE BUILDING BUFFER STOCKS IN ANTICIPATION OF FURTHER DISRUPTION AS SUPPLY SHORTAGES PERSIST: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

BUSINESSES CONTINUE BUILDING BUFFER STOCKS IN ANTICIPATION OF FURTHER DISRUPTION AS SUPPLY SHORTAGES PERSIST: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Manufacturers’ reports of supply shortages among their highest since late 2022, signaling…
From the Lab to the Road: How Training Science Arrives in Brazil with the HUAWEI WATCH GT Runner 2

From the Lab to the Road: How Training Science Arrives in Brazil with the HUAWEI WATCH GT Runner 2

Two-time Olympic champion runs in Brazil with the smartwatch he helped create…

POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement

GUANGZHOU, China, July 13, 2026 /PRNewswire/ — POMDOCTOR LIMITED ("Pomdoctor" or the…

Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China

SHANGHAI, July 13, 2026 /PRNewswire/ — Delonix Bioworks, a clinical-stage biotechnology company…